Literature DB >> 24906954

A MicroRNA Profile in Fmr1 Knockout Mice Reveals MicroRNA Expression Alterations with Possible Roles in Fragile X Syndrome.

Ting Liu1, Rui-Ping Wan, Ling-Jia Tang, Shu-Jing Liu, Hai-Jun Li, Qi-Hua Zhao, Wei-Ping Liao, Xiao-Fang Sun, Yong-Hong Yi, Yue-Sheng Long.   

Abstract

Fragile X syndrome (FXS), a common form of inherited mental retardation, is caused by a loss of expression of the fragile X mental retardation protein (FMRP). FMRP is involved in brain functions by interacting with mRNAs and microRNAs (miRNAs) that selectively control gene expression at translational level. However, little is known about the role of FMRP in regulating miRNA expression. Here, we found a development-dependant dynamic expression of Fmr1 gene (encoding FMRP) in mouse hippocampus with a small peak at postnatal day 7 (P7). MiRNA microarray analysis showed that the levels of 38 miRNAs showed a significant increase with about 15 ~ 250-folds and the levels of 26 miRNAs showed a significant decrease with only about 2 ~ 4-folds in the hippocampus of P7 Fmr1 knockout (KO) mice. The qRT-PCR assay showed that nine of the most increased miRNAs (>100-folds in microarrays) increased about 40 ~ 70-folds and their pre-miRNAs increased about 5 ~ 10-folds, but no significant difference in their pri-miRNA levels was observed, suggesting that the alterations of partial miRNAs are an indirect consequence of FMRP lacking. We further demonstrated that a set of protein-coding mRNAs, potentially targeted by the nine miRNAs, were down-regulated in the hippocampus of Fmr1 KO mice. Finally, luciferase assays demonstrated that miR-34b, miR-340, and miR-148a could down-regulate the reporter gene expression by interacting with the Met 3' UTR. Taken together, these findings suggest that the miRNA expression alterations resulted from the absence of FMRP might contribute to molecular pathology of FXS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906954     DOI: 10.1007/s12035-014-8770-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  57 in total

1.  Genetic disruption of Met signaling impairs GABAergic striatal development and cognition.

Authors:  G J Martins; M Shahrokh; E M Powell
Journal:  Neuroscience       Date:  2010-12-31       Impact factor: 3.590

2.  Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

Authors:  Na Liu; Nian-Yong Chen; Rui-Xue Cui; Wen-Fei Li; Yan Li; Rong-Rong Wei; Mei-Yin Zhang; Ying Sun; Bi-Jun Huang; Mo Chen; Qing-Mei He; Ning Jiang; Lei Chen; William C S Cho; Jing-Ping Yun; Jing Zeng; Li-Zhi Liu; Li Li; Ying Guo; Hui-Yun Wang; Jun Ma
Journal:  Lancet Oncol       Date:  2012-05-03       Impact factor: 41.316

3.  Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.

Authors:  David Hessl; Flora Tassone; Danuta Z Loesch; Elizabeth Berry-Kravis; Maureen A Leehey; Louise W Gane; Ingrid Barbato; Cathlin Rice; Emma Gould; Deborah A Hall; James Grigsby; Jacob A Wegelin; Susan Harris; Foster Lewin; Dahlia Weinberg; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

4.  Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons.

Authors:  L N Antar; J B Dictenberg; M Plociniak; R Afroz; G J Bassell
Journal:  Genes Brain Behav       Date:  2005-08       Impact factor: 3.449

5.  A nuclear role for the Fragile X mental retardation protein.

Authors:  R A Fridell; R E Benson; J Hua; H P Bogerd; B R Cullen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation.

Authors:  Juan Nunez-Iglesias; Chun-Chi Liu; Todd E Morgan; Caleb E Finch; Xianghong Jasmine Zhou
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

7.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

8.  Male with typical fragile X phenotype is deleted for part of the FMR1 gene and for about 100 kb of upstream region.

Authors:  Y Trottier; G Imbert; A Poustka; J P Fryns; J L Mandel
Journal:  Am J Med Genet       Date:  1994-07-15

9.  Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA.

Authors:  Ernest Blackwell; Xing Zhang; Stephanie Ceman
Journal:  Hum Mol Genet       Date:  2010-01-11       Impact factor: 6.150

10.  A distinct class of small RNAs arises from pre-miRNA-proximal regions in a simple chordate.

Authors:  Weiyang Shi; David Hendrix; Mike Levine; Benjamin Haley
Journal:  Nat Struct Mol Biol       Date:  2009-01-18       Impact factor: 15.369

View more
  17 in total

1.  Acute Ethanol Produces Ataxia and Induces Fmr1 Expression via Histone Modifications in the Rat Cerebellum.

Authors:  Russell S Dulman; James Auta; Tara Teppen; Subhash C Pandey
Journal:  Alcohol Clin Exp Res       Date:  2019-05-14       Impact factor: 3.455

Review 2.  Dysregulation and restoration of translational homeostasis in fragile X syndrome.

Authors:  Joel D Richter; Gary J Bassell; Eric Klann
Journal:  Nat Rev Neurosci       Date:  2015-09-09       Impact factor: 34.870

Review 3.  Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.

Authors:  Christina Gross; Anne Hoffmann; Gary J Bassell; Elizabeth M Berry-Kravis
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

4.  Involvement of FMRP in Primary MicroRNA Processing via Enhancing Drosha Translation.

Authors:  Rui-Ping Wan; Lin-Tao Zhou; Hai-Xuan Yang; Yong-Ting Zhou; Shun-Hua Ye; Qi-Hua Zhao; Mei-Mei Gao; Wei-Ping Liao; Yong-Hong Yi; Yue-Sheng Long
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

Review 5.  Reactivation of FMR1 gene expression is a promising strategy for fragile X syndrome therapy.

Authors:  Ekaterina M Shitik; Anastasia A Velmiskina; Alexander A Dolskiy; Dmitry V Yudkin
Journal:  Gene Ther       Date:  2020-03-12       Impact factor: 5.250

Review 6.  The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.

Authors:  Iman Imtiyaz Ahmed Juvale; Ahmad Tarmizi Che Has
Journal:  J Mol Neurosci       Date:  2021-03-27       Impact factor: 3.444

7.  MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del.

Authors:  Dejian Zhao; Mingyan Lin; Jian Chen; Erika Pedrosa; Anastasia Hrabovsky; H Matthew Fourcade; Deyou Zheng; Herbert M Lachman
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 8.  Common microRNAs Target Established ASD Genes.

Authors:  Sharmila Banerjee-Basu; Eric Larsen; Sabina Muend
Journal:  Front Neurol       Date:  2014-10-28       Impact factor: 4.003

9.  Impulsivity and comorbid traits: a multi-step approach for finding putative responsible microRNAs in the amygdala.

Authors:  Andrzej Z Pietrzykowski; Sabine Spijker
Journal:  Front Neurosci       Date:  2014-12-11       Impact factor: 4.677

10.  Prenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brain.

Authors:  Yuta Hara; Yukio Ago; Erika Takano; Shigeru Hasebe; Takanobu Nakazawa; Hitoshi Hashimoto; Toshio Matsuda; Kazuhiro Takuma
Journal:  Mol Autism       Date:  2017-06-28       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.